Home > ABOUT > Our customers



October, 2013 UPDATE:

Screening Compounds

Fragment library


Customers
  • Otava collaborates with some of the largest pharmaceutical and biotechnology companies in the world as supplier of compounds for HTS, Building Blocks and Targeted Libraries:

-Actelion Pharmaceuticals Ltd (Switzerland)

-AstraZeneca Pharmaceuticals (UK)

-AstraZeneca R&D (Sweden)

-AstraZeneca R&D Montreal (Canada)

-Bayer Schering Pharma (Germany)

-Bayer CropScience GmbH (Germany)

-Boehringer Ingelheim GmbH (Austria)

-Campbell Family Institute for Breast Cancer Research, University Health Network (Canada)

-CARLOERBA-SDS (France)

-Chemfidence GmbH (Germany)

-Chem-Impex International Inc (USA)

-CV Therapeutics, Inc. (USA)

-Dana-Farber Cancer Institute - Harvard Medical School (USA)

-Dow AgroSciences (USA)

-Elan Pharmaceuticals (USA)

-Eli Lilly and Company (USA)

-EMD Biosciences, Inc. (USA)

-Galapagos (Belgium)

-Genentech, Inc. (USA)

-GlaxoSmithKline (UK)

-GrĂ¼nenthal GmbH (Germany)

-LEO Pharma A/S (Denmark)

-Merck (USA)

-Merck KGaA (Germany)

-North Carolina State University (USA)

-Otsuka Maryland Medicinal Laboratories (USA)

-Pfizer (USA)

-Sanofi-Aventis (USA)

-Sanofi-Aventis Deutschland GmbH(Germany)

-Schering Corporation(USA)

-Sigma Aldrich (France)

-Sigma-Aldrich (USA)

-Solvay Pharmaceuticals GmbH (Germany)

-Summit Pharmaceuticals International Corporation (Japan)

-SuperGen, Inc (USA)

-Syngenta (UK)

-Takeda Cambridge Limited (UK)

-UCB Pharma SA (Belgium)

-Vertex Pharmaceuticals LLC (USA)

-Wako Pure Chemical Industries, Ltd. (Japan)